MEDVi vs SynergyRx: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent researchHow we rank →

MEDVi beats SynergyRx overall, scoring 7.7/10 vs 7.6/10. SynergyRx is more affordable at $199/mo vs $299/mo. Choose MEDVi for users who want a low entry price with oral and injectable co. Choose SynergyRx for users who want predictable bundled pricing with 24/7 support.

A side-by-side comparison of MEDVi and SynergyRx covering pricing, scores, medication types, insurance, and more to help you decide.

Higher Rated

MEDVi

#22 of 48
7.7/10

MEDVi is a compounded GLP-1 telehealth platform offering both oral tablets and injectable semaglutide and tirzepatide, with micro-dosing options for side-effect-sensitive patients. $179/mo entry pricing, free shipping, and a streamlined intake — one of the broader compounded mixes among independent telehealth providers in 2026.

Visit MEDVi

SynergyRx

#24 of 48
7.6/10

Bundled GLP-1 program with predictable pricing and round-the-clock support access for peace of mind.

Visit SynergyRx
FeatureMEDViSynergyRx
Our Score7.7/107.6/10
Starting Price$299/mo$199/mo
Medication TypeBothBoth
Insurance AcceptedNoNo
Best ForUsers who want a low entry price with oral and injectable compounded optionsUsers who want predictable bundled pricing with 24/7 support access
Ranking#22#24

Pros & Cons Compared

MEDVi

Pros

  • +One of the few compounded providers offering both oral tablets and injectable semaglutide
  • +Micro-dosing options available — can start at sub-standard doses for patients concerned about side effects
  • +Sleek onboarding experience with clear progress tracking through their patient portal
  • +$179/mo is competitive for a platform with both oral and injectable compounded formulations

Cons

  • Compounded medications only — no path to brand-name Wegovy or Zepbound through their platform
  • No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms

SynergyRx

Pros

  • +Oral dissolving tablets for BOTH semaglutide AND tirzepatide — one of the few platforms with needle-free tirzepatide
  • +Free expedited shipping included with all orders
  • +24/7 support with unlimited messaging — no per-visit fees for follow-up questions or dose adjustments
  • +Both compounded and brand-name options available (Ozempic, Wegovy, Mounjaro)

Cons

  • Casper, WY registration address and limited independent reviews raise legitimacy questions
  • Brand-name pricing ($499-947/mo) is very high compared to direct manufacturer programs like LillyDirect
  • Company history, founding date, and ownership structure are not publicly disclosed

Our Verdict

MEDVi edges out SynergyRx with a score of 7.7/10 vs 7.6/10. If budget is your priority, SynergyRx starts at $199/mo compared to MEDVi's $299/mo. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options. Choose SynergyRx if you want: users who want predictable bundled pricing with 24/7 support access.

Still undecided? Editor's #1 Overall Pick

Eden Health GLP-1

$249/mo · 8.9/10 · Both

If neither MEDVi nor SynergyRx feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Eden Health GLP-1 — strongest balance of clinical oversight, transparent pricing, and verified availability.

Try MEDVi

Starting at $299/mo

Visit MEDVi

Try SynergyRx

Starting at $199/mo

Visit SynergyRx

Related comparisons

Other matchups readers comparing MEDVi or SynergyRx tend to look at next.

Top Picks

Four programs our readers click through most.

Eden Health GLP-1

8.9/10
$249/mo·Brand & Compounded

Embody

7.3/10
$299/mo·Compounded

Gala

7.2/10
$149/mo·Brand & Compounded

Affiliate links — we earn a commission at no extra cost to you. Selection reflects what readers convert through, not editorial endorsement. Full ranking + methodology at glp1picks.com.